| Item Type | Name |
|
Concept
|
Prostate-Specific Antigen
|
|
Concept
|
Prostate
|
|
Academic Article
|
Update on transrectal ultrasound-guided needle biopsy of the prostate.
|
|
Academic Article
|
Ratio of free-to-total prostate specific antigen correlates with tumor volume in patients with increased prostate specific antigen.
|
|
Academic Article
|
Prediction of tumour volume and pathological stage in radical prostatectomy specimens is not improved by taking more prostate needle-biopsy cores.
|
|
Academic Article
|
Percent of cancer in the biopsy set predicts pathological findings after prostatectomy.
|
|
Academic Article
|
The free/total prostate-specific antigen ratio (%fPSA) is the best predictor of tumor involvement in the radical prostatectomy specimen among men with an elevated PSA.
|
|
Academic Article
|
Significance of atypical and suspicious small acinar proliferations, and high grade prostatic intraepithelial neoplasia on prostate biopsy: implications for cancer detection and biopsy strategy.
|
|
Academic Article
|
Effects of obesity and height on prostate-specific antigen (PSA) and percentage of free PSA levels among African-American and Caucasian men.
|
|
Academic Article
|
Erectile function outcome reporting after clinically localized prostate cancer treatment.
|
|
Academic Article
|
Delay in the progression of low-risk prostate cancer: rationale and design of the Reduction by Dutasteride of Clinical Progression Events in Expectant Management (REDEEM) trial.
|
|
Academic Article
|
Risk factors for urothelial carcinoma of the prostate in patients undergoing radical cystoprostatectomy for bladder cancer.
|
|
Academic Article
|
Oxidative stress measured by urine F2-isoprostane level is associated with prostate cancer.
|
|
Academic Article
|
Positive surgical margins at radical prostatectomy: much ado about nothing?
|
|
Academic Article
|
Urology perspective on the expanding world of germline testing for prostate cancer.
|
|
Academic Article
|
Editorial Comment.
|
|
Academic Article
|
The changing landscape in the management of newly diagnosed castration sensitive metastatic prostate cancer.
|
|
Academic Article
|
Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer.
|
|
Academic Article
|
Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART I.
|
|
Academic Article
|
Incidence and clinical significance of false-negative sextant prostate biopsies.
|
|
Academic Article
|
Incidence and location of prostate and urothelial carcinoma in prostates from cystoprostatectomies: implications for possible apical sparing surgery.
|
|
Academic Article
|
Morbidity and efficacy of genitofemoral nerve grafts with radical retropubic prostatectomy.
|
|
Academic Article
|
Mechanisms leading to the development of hormone-resistant prostate cancer.
|
|
Academic Article
|
Androgen and anti-androgen treatment modulates androgen receptor activity and DJ-1 stability.
|
|
Academic Article
|
Tumour volume is an independent predictor of prostate-specific antigen recurrence in patients undergoing radical prostatectomy for clinically localized prostate cancer.
|
|
Academic Article
|
The association between body size, prostate volume and prostate-specific antigen.
|
|
Academic Article
|
Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes.
|
|
Academic Article
|
Effect of a large prostate gland on open and robotically assisted laparoscopic radical prostatectomy.
|
|
Academic Article
|
Incidence and location of prostate and urothelial carcinoma in prostates from cystoprostatectomies: implications for possible apical sparing surgery.
|
|
Academic Article
|
Smaller prostate size predicts high grade prostate cancer at final pathology.
|
|
Academic Article
|
The associations between statin use and prostate cancer screening, prostate size, high-grade prostatic intraepithelial neoplasia (PIN), and prostate cancer.
|
|
Academic Article
|
Prostate size as a predictor of Gleason score upgrading in patients with low risk prostate cancer.
|
|
Academic Article
|
Racial variation in the quality of surgical care for prostate cancer.
|
|
Academic Article
|
Castration-resistant prostate cancer: AUA Guideline.
|
|
Academic Article
|
An expressed retrogene of the master embryonic stem cell gene POU5F1 is associated with prostate cancer susceptibility.
|
|
Academic Article
|
Castration-resistant prostate cancer: AUA guideline amendment.
|
|
Academic Article
|
The Evolving Biology of Castration-Resistant Prostate Cancer: Review of Recommendations From the Prostate Cancer Clinical Trials Working Group 3.
|
|
Academic Article
|
Advances in the management of castration resistant prostate cancer.
|
|
Academic Article
|
Recent trends in the management of advanced prostate cancer.
|
|
Academic Article
|
Optimizing the role of androgen deprivation therapy in advanced prostate cancer: Challenges beyond the guidelines.
|
|
Academic Article
|
Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019.
|
|
Academic Article
|
Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART II.
|
|
Academic Article
|
Urothelial carcinoma of the prostate.
|
|
Academic Article
|
Prostate volume modifies the association between obesity and prostate cancer or high-grade prostatic intraepithelial neoplasia.
|
|
Academic Article
|
A comparison of the incidence and location of positive surgical margins in robotic assisted laparoscopic radical prostatectomy and open retropubic radical prostatectomy.
|
|
Academic Article
|
Association between prostate-specific antigen and leptin, adiponectin, HbA1c or C-peptide among African-American and Caucasian men.
|
|
Academic Article
|
A critical review of clinical practice guidelines for the management of clinically localized prostate cancer.
|
|
Academic Article
|
Robotic assisted laparoscopic prostatectomy versus radical retropubic prostatectomy for clinically localized prostate cancer: comparison of short-term biochemical recurrence-free survival.
|
|
Academic Article
|
Prostate cancer serum biomarker discovery through proteomic analysis of alpha-2 macroglobulin protein complexes.
|
|
Academic Article
|
NCCN clinical practice guidelines in oncology: prostate cancer early detection.
|
|
Academic Article
|
Spurious elevation of serum PSA after curative treatment for prostate cancer: clinical consequences and the role of heterophilic antibodies.
|
|
Academic Article
|
Prostate cancer: Could sensitive PSA assays expedite salvage radiotherapy?
|
|
Academic Article
|
Biochemical recurrence-free survival after robotic-assisted laparoscopic vs open radical prostatectomy for intermediate- and high-risk prostate cancer.
|
|
Academic Article
|
Castration-Resistant Prostate Cancer: AUA Guideline Amendment 2015.
|
|
Academic Article
|
Castration-Resistant Prostate Cancer: An Algorithmic Approach.
|
|
Academic Article
|
Transition from androgenic to neurosteroidal action of 5a-androstane-3a, 17ß-diol through the type A ?-aminobutyric acid receptor in prostate cancer progression.
|
|
Academic Article
|
Castration-Resistant Prostate Cancer: AUA Guideline Amendment 2018.
|
|
Academic Article
|
8q24 genetic variation and comprehensive haplotypes altering familial risk of prostate cancer.
|
|
Academic Article
|
Hormonal therapy for metastatic prostate cancer: issues of timing and total androgen ablation.
|
|
Academic Article
|
Glutathione S-transferase PI (GST-pi) class expression by immunohistochemistry in benign and malignant prostate tissue.
|
|
Academic Article
|
Pathological staging and biochemical recurrence after neoadjuvant androgen deprivation therapy in combination with radical prostatectomy in clinically localized prostate cancer: results of a phase II study.
|
|
Academic Article
|
Clinical significance of repeat sextant biopsies in prostate cancer patients.
|
|
Academic Article
|
Repeat transrectal ultrasound-guided prostate biopsy: a strategy to improve the reliability of needle biopsy grading in patients with well-differentiated prostate cancer.
|
|
Academic Article
|
[Incidence and clinical significance of false-negative sextant biopsies of the prostate].
|
|
Academic Article
|
Intrarectal lidocaine during transrectal prostate biopsy: results of a prospective double-blind randomized trial.
|
|
Academic Article
|
Health related quality of life assessment after radical prostatectomy in men with prostate specific antigen only recurrence.
|
|
Academic Article
|
Carcinoma in situ and tumor multifocality predict the risk of prostatic urethral involvement at radical cystectomy in men with transitional cell carcinoma of the bladder.
|
|
Academic Article
|
Randomized prospective evaluation of extended versus limited lymph node dissection in patients with clinically localized prostate cancer.
|
|
Academic Article
|
Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot study.
|
|
Academic Article
|
Guideline for the management of clinically localized prostate cancer: 2007 update.
|
|
Academic Article
|
Association of nonsteroidal anti-inflammatory drugs, prostate specific antigen and prostate volume.
|
|
Academic Article
|
Complications of pelvic lymph node dissection for prostate cancer.
|
|
Academic Article
|
Long-term efficacy and tolerability of once-yearly histrelin acetate subcutaneous implant in patients with advanced prostate cancer.
|
|
Academic Article
|
Optimization of initial prostate biopsy in clinical practice: sampling, labeling and specimen processing.
|
|
Academic Article
|
The lack of predictive value of prostate specific antigen density in the detection of prostate cancer in patients with normal rectal examinations and intermediate prostate specific antigen levels.
|
|
Academic Article
|
Prognostic significance of prostate-specific antigen in stage T1c prostate cancer treated by radical prostatectomy.
|
|
Academic Article
|
Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment.
|